Аннотация:
Background. Rowatinex is a combined drug based on plant terpenes which provides diuretic, anti-inflammatory and antispasmodic effect. A use of herbal preparation Rowatinex in patients with urinary stone disease after extracorporeal shock-wave therapy (ESWL) is analyzed in the article. Aim. To clarify the efficiency of the drug Rowatinex in patients with urinary stone disease after ESWL. Materials and methods. All patients were divided into two groups depending on therapy administered after ESWL. In main group (n=150) patients received Rowatinex, while in control group (n=70), antispasmodics were administered. Spontaneous passage of fragments was observed in 104 patients in main group (69.3[%]) and 30 patients in control group (42.9[%]). Results. When studying the effect of therapy on the changes of complete blood count, biochemical panel and daily excretion of some substances (magnesium, uric acid, calcium, etc) there were no significant differences between main group and control group.
Ключевые слова:
Extracorporeal shock-wave therapy; Phytotherapy; Rowatinex; Terpenes; Urinary stone disease; Urolithiasis
terpene; clinical trial; human; lithotripsy; multimodality cancer therapy; nephrolithiasis; shock wave therapy; urolithiasis; Combined Modality Therapy; Extracorporeal Shockwave Therapy; Humans; Kidney Calculi; Lithotripsy; Terpenes; Urinary Calculi
Руденко В. И. Вадим Игорьевич 1966-
Рапопорт Л. М. Леонид Моисеевич 1956-
Демидко Ю. Л. Юрий Леонидович 1968-
Демидко Л. С. Лилия Саидовна 1975-
Иноятов Г. С.
Алленов С. Н. Сергей Николаевич 1968-
Rudenko V. I. Vadim Igoryevich 1966-
Rapoport L. M. Leonid Moiseevich 1956-
Demidko Yu. L. Yurij Leonidovich 1968-
Demidko L. S. Liliya Saidovna 1975-
Inoyatov G. S.
Allenov S. N. Sergej Nikolaevich 1968-
Clinical value of herbal terpenes after extracorporeal shock-wave therapy
Текст визуальный непосредственный
Урология
Бионика Медиа
Т. 2019, Вып. 3 С. 43-49
2019
Статья
Extracorporeal shock-wave therapy Phytotherapy Rowatinex Terpenes Urinary stone disease Urolithiasis
terpene clinical trial human lithotripsy multimodality cancer therapy nephrolithiasis shock wave therapy urolithiasis Combined Modality Therapy Extracorporeal Shockwave Therapy Humans Kidney Calculi Lithotripsy Terpenes Urinary Calculi
Background. Rowatinex is a combined drug based on plant terpenes which provides diuretic, anti-inflammatory and antispasmodic effect. A use of herbal preparation Rowatinex in patients with urinary stone disease after extracorporeal shock-wave therapy (ESWL) is analyzed in the article. Aim. To clarify the efficiency of the drug Rowatinex in patients with urinary stone disease after ESWL. Materials and methods. All patients were divided into two groups depending on therapy administered after ESWL. In main group (n=150) patients received Rowatinex, while in control group (n=70), antispasmodics were administered. Spontaneous passage of fragments was observed in 104 patients in main group (69.3[%]) and 30 patients in control group (42.9[%]). Results. When studying the effect of therapy on the changes of complete blood count, biochemical panel and daily excretion of some substances (magnesium, uric acid, calcium, etc) there were no significant differences between main group and control group.